| Income Statement |
| Total Revenue | 249.70M |
|
| Revenues (USD) | 249.70M |
| Cost of Revenue | 9.00M |
| Gross Profit | 240.70M |
| Operating Expenses | 76.60M |
| Research and Development Expense | 52.60M |
| Selling, General and Administrative Expense | 24.00M |
| Operating Income | 164.10M |
| Income Tax Expense | 200.00K |
| Net Income | 169.40M |
| Net Income Common Stock | 169.40M |
| Net Income Common Stock (USD) | 169.40M |
| Consolidated Income | 169.40M |
| Earnings per Basic Share | 2.61 |
| Earnings per Basic Share (USD) | 2.61 |
| Earnings per Diluted Share | 2.58 |
| Earning Before Interest & Taxes (EBIT) | 169.60M |
| Earning Before Interest & Taxes (USD) | 169.60M |
| Weighted Average Shares | 64.80M |
| Weighted Average Shares Diluted | 65.70M |
| Balance Sheet |
| Cash and Equivalents | 94.30M |
| Cash and Equivalents (USD) | 94.30M |
| Investments | 473.60M |
| Investments Current | 473.60M |
| Trade and Non-Trade Receivables | 54.30M |
| Current Assets | 652.20M |
| Property, Plant & Equipment Net | 12.30M |
| Total Assets | 675.10M |
| Debt Current | 1.90M |
| Total Debt | 8.00M |
| Current Liabilities | 82.50M |
| Debt Non-Current | 6.10M |
| Total Liabilities | 112.90M |
| Accumulated Retained Earnings (Deficit) | -1.50B |
| Accumulated Other Comprehensive Income | -800.00K |
| Shareholders Equity | 562.20M |
| Shareholders Equity (USD) | 562.20M |
| Assets Non-Current | 22.90M |
| Total Debt (USD) | 8.00M |
| Liabilities Non-Current | 30.40M |
| Trade and Non-Trade Payables | 52.20M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.20M |
| Net Cash Flow from Financing | 400.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.00M |
| Capital Expenditure | -200.00K |
| Issuance (Purchase) of Equity Shares | 500.00K |
| Issuance (Repayment) of Debt Securities | -100.00K |
| Net Cash Flow from Investing | 54.90M |
| Net Cash Flow - Investment Acquisitions and Disposals | 55.10M |
| Net Cash Flow from Operations | -48.30M |
| Share Based Compensation | 5.90M |